Forgot your password?
typodupeerror

Comment Everyone's looking at the wrong numbers (Score 1) 481

It is a bone-headed decision from the customer perspective. No going concern would completely disregard the preferences of their client base in this manner unless there was something more compelling, such as the cost side. From CNN Money in July: "Pachter predicts Netflix's streaming content licensing costs will rise from $180 million in 2010 to a whopping $1.98 billion in 2012." (http://money.cnn.com/2011/07/08/technology/netflix_starz_contract/index.htm).

Netflix is looking at a 10 fold increase in their licensing costs. They can't pass that on to their customers, the demand side is too price sensitive. Their former corporate structure probably restricted their ability to negotiate these fees because they couldn't differentiate the user bases, streaming from physical. The key difference with this change is that this is the only way to separate the client bases into two separate companies.

Their setting themselves up for the 2012 negotiations with the content providers. This gives the two companies additional leverage and could potentially save them $1 billion (give or take a few hundred million dollars) in the process. In the long run, it probably is the best way to serve their customers, and their shareholders.

Government

SFLC Wants To Avoid Death by Code 247

foregather writes "The Software Freedom Law Center has released some independent research on the safety of software close to our hearts: that inside of implantable medical devices like pacemakers and insulin pumps. It turns out that nobody is minding the store at the regulatory level and patients and doctors are blocked from examining the source code keeping them alive. From the article: 'The Food and Drug Administration (FDA) is responsible for evaluating the risks of new devices and monitoring the safety and efficacy of those currently on market. However, the agency is unlikely to scrutinize the software operating on devices during any phase of the regulatory process unless a model that has already been surgically implanted repeatedly malfunctions or is recalled. ... Despite the crucial importance of these devices and the absence of comprehensive federal oversight, medical device software is considered the exclusive property of its manufacturers, meaning neither patients nor their doctors are permitted to access their IMD's source code or test its security.'"

Slashdot Top Deals

"Here comes Mr. Bill's dog." -- Narrator, Saturday Night Live

Working...